Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising incidence of infectious mononucleosis (IM) and Growing awareness towards mononucleosis
4.1.2. Restraints:
4.1.2.1. Limitations of Available Tests for the Diagnosis of Mononucleosis
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1 Porter’s Five Forces Analysis
5.2 Regulatory Analysis
5.3 Supply Chain Analysis
5.4 Product Innovations
5.5 Unmet Needs
6. By Test Type
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
6.1.2. Market Attractiveness Index, By Test Type Segment
6.2. Epstein Barr Virus (EBV) Antibody Test
6.2.1.1. Introduction
6.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
6.3. Monospot Test
6.4. Complete Blood Count Test
7. By End-User
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
7.1.2. Market Attractiveness Index, By End-User Segment
7.2. Hospitals
7.2.1.1. Introduction
7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Laboratories
7.4. Others
8. By Region
8.1. Introduction
8.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.2.5.1. U.S.
8.2.5.2. Canada
8.2.5.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.3.5.1. Germany
8.3.5.2. U.K.
8.3.5.3. France
8.3.5.4. Italy
8.3.5.5. Spain
8.3.5.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.4.5.1. Brazil
8.4.5.2. Argentina
8.4.5.3. Rest of South America
8.5. Asia Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.5.5.1. China
8.5.5.2. India
8.5.5.3. Japan
8.5.5.4. Australia
8.5.5.5. Rest of Asia Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
9. Competitive Landscape
9.1. Key Developments and Strategies
9.2. Company Share Analysis
9.3. Test Types Benchmarking
9.4. List of Key Companies to Watch
10. Company Profiles
10.1 Bio-Rad Laboratories Inc.*
10.1.1 Company Overview
10.1.2 Product Portfolio and Description
10.1.3 Key Highlights
10.1.4 Financial Overview
10.2 Thermo Fischer Scientific Inc.
10.3 Abbott Laboratories
10.4 Cardinal Health Inc.
10.5 Arlington Scientific Inc.
10.6 Quidel Corporation
10.7 Beckman Coulter Inc.
10.8 Immunostics Inc.
10.9 Meridian Bioscience
10.10 Sekisui Diagnostics
LIST NOT EXHAUSTIVE
11. Global Mononucleosis Diagnostic Market – DataM
11.1. Appendix
11.2. About Us and Distribution Channel
11.3. Contact Us